Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Senhwa Announces Multiple IND application submissions to U.S. FDA for Silmitasertib as a Potential Treatment for COVID-19 2020-11-02 22:00
CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates 2020-11-02 19:00
Samsung Biologics Establishes Partnership with China Biotech GeneQuantum Healthcare to Collaborate on ADC Development 2020-11-02 08:27
TaiGen Announces FDA Approval of IND for Its Flu Antiviral TG-1000 2020-11-02 07:30
Hyundai Bioscience: A Korean bio-tech solves the bioavailability issue of Niclosamide 2020-10-29 20:00
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center 2020-10-29 08:38
Gracell Biotechnologies Raises $100 Million in Series C Funding to Advance Next Generation CAR-T Cell Therapies 2020-10-28 21:00
Genome & Company announces first patient dosed in Phase 1/1b study of GEN-001, an immuno-oncology microbiome therapeutic, in combination with avelumab 2020-10-27 21:00
I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2020-10-27 20:05
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study 2020-10-27 10:03
Reistone Biopharma Announces Positive Topline Results from Phase 2 Clinical Trial Evaluating SHR0302, a JAK1 Inhibitor for the Treatment of Moderate-to-Severe Atopic Dermatitis 2020-10-26 19:40
PharmAbcine to participate at BIO-Europe 2020 2020-10-23 20:00
Longevity Acquisition Corporation Announces Signing of Definitive Merger Agreement 2020-10-22 14:00
Samsung Biologics' strategic business operations continue to support strong third quarter earnings 2020-10-21 19:00
Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment 2020-10-20 19:00
Samsung Biologics partners with BioEleven for cancer immunotherapy development and manufacturing 2020-10-19 19:00
Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Conference 2020-10-16 20:00
VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020 2020-10-14 20:00
Kanaph Therapeutics Closes 21M USD Series B Funding 2020-10-13 11:30
Gannex Received U.S. IND Approval for Its NASH Drug Candidate ASC42，an FXR Agonist 2020-10-12 08:30
1 97 98 99 100 101 203